Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
First-Line Treatment of Chronic Lymphocytic Leukemia
.
Show all posts
Showing posts with label
First-Line Treatment of Chronic Lymphocytic Leukemia
.
Show all posts
Tuesday, May 24, 2016
FDA Approves Imbruvica (ibrutinib) for the First-Line Treatment of Chronic Lymphocytic Leukemia
›
In continuation of my update on Ibrutinib AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced the U.S. Foo...
›
Home
View web version
